• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含铀材料在模拟肺液中的体外溶出研究。

In vitro dissolution studies of uranium bearing material in simulated lung fluid.

作者信息

Sdraulig S, Franich R, Tinker R A, Solomon S, O'Brien R, Johnston P N

机构信息

Australian Radiation Protection and Nuclear Safety Agency, 619 Lower Plenty Road, Yallambie, VIC 3085, Australia.

出版信息

J Environ Radioact. 2008 Mar;99(3):527-38. doi: 10.1016/j.jenvrad.2007.08.009. Epub 2007 Oct 18.

DOI:10.1016/j.jenvrad.2007.08.009
PMID:17949865
Abstract

Inhaled uranium (U) bearing material will partially dissolve in the fluid lining of the lung, followed by a combination of retention, re-distribution, and excretion of the U. The rate of dissolution influences the retention time at the site of deposition, and the extent to which the material is available for re-distribution to other tissues. The consequential radiation dose is dependent upon the material distribution in the body and the exposure time to various tissues. The International Commission on Radiological Protection, ICRP 66 [International Commission on Radiological Protection (ICRP), 1994. Human Respiratory Tract Model for Radiological Protection. ICRP Publication 66] recommends the use of experimentally determined solubility coefficients in dose modelling. Material specific absorption parameters allow for better dose estimation than using ICRP default values for F (fast), M (moderate) and S (slow) classifications of U compounds. In vitro dissolution tests were carried out on U material collected from two U mines located in Australia. A static technique was designed in which particle samples were sandwiched between two 0.1-mum pore size membrane filters. The filter sandwich was exposed to a solvent (simulated lung fluid) for selected time intervals, at controlled test conditions for temperature and pH. The collected solution was analysed for U concentration using ICP-MS. The resulting dissolution curves were fitted with a double or triple exponential equation to determine the dissolution coefficients.

摘要

吸入含铀(U)物质会部分溶解于肺内的液体衬里中,随后铀会经历滞留、重新分布和排泄的过程。溶解速率会影响其在沉积部位的滞留时间,以及该物质可重新分布到其他组织的程度。由此产生的辐射剂量取决于该物质在体内的分布以及对各种组织的暴露时间。国际放射防护委员会(ICRP)第66号出版物[国际放射防护委员会(ICRP),1994年。用于放射防护的人类呼吸道模型。ICRP第66号出版物]建议在剂量建模中使用实验确定的溶解度系数。与使用ICRP对铀化合物的F(快)、M(中)和S(慢)分类的默认值相比,材料特定的吸收参数能实现更好的剂量估算。对从澳大利亚的两座铀矿采集的铀物质进行了体外溶解试验。设计了一种静态技术,其中将颗粒样品夹在两个孔径为0.1微米的膜过滤器之间。在温度和pH值可控的测试条件下,将过滤器夹层在选定的时间间隔内暴露于一种溶剂(模拟肺液)中。使用电感耦合等离子体质谱法(ICP-MS)分析收集到的溶液中的铀浓度。将得到的溶解曲线与双指数或三指数方程拟合,以确定溶解系数。

相似文献

1
In vitro dissolution studies of uranium bearing material in simulated lung fluid.含铀材料在模拟肺液中的体外溶出研究。
J Environ Radioact. 2008 Mar;99(3):527-38. doi: 10.1016/j.jenvrad.2007.08.009. Epub 2007 Oct 18.
2
Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN.测定NRCN铀加工厂中放射性气溶胶的溶解度和粒径分布。
Radiat Prot Dosimetry. 2008;131(4):418-24. doi: 10.1093/rpd/ncn206. Epub 2008 Aug 1.
3
Physicochemical characterization of Capstone depleted uranium aerosols IV: in vitro solubility analysis.顶石贫化铀气溶胶的物理化学特性IV:体外溶解度分析
Health Phys. 2009 Mar;96(3):292-305. doi: 10.1097/01.HP.0000291946.32717.2b.
4
Effective dose scaling factors for use with uranium series cascade impactor data: a reassessment using the IMBA code.
Health Phys. 2006 Oct;91(4):331-7. doi: 10.1097/01.HP.0000218427.44413.c7.
5
Particle Size-dependent Dissolution of Uranium Aerosols in Simulated Lung Fluid: A Case Study in a Nuclear Fuel Fabrication Plant.粒径依赖性铀气溶胶在模拟肺液中的溶解:核燃料制造厂的案例研究。
Health Phys. 2022 Jul 1;123(1):11-27. doi: 10.1097/HP.0000000000001564. Epub 2022 May 6.
6
Radiation dose assessment of exposure to depleted uranium.贫铀暴露的辐射剂量评估
J Expo Sci Environ Epidemiol. 2009 Jul;19(5):502-14. doi: 10.1038/jes.2008.40. Epub 2008 Jul 2.
7
A respiratory model for uranium aluminide based on occupational data.基于职业数据的铝化铀呼吸系统模型。
J Radiol Prot. 2005 Dec;25(4):405-16. doi: 10.1088/0952-4746/25/4/004. Epub 2005 Dec 5.
8
US Transuranium and Uranium Registries case study on accidental exposure to uranium hexafluoride.美国超铀元素与铀注册中心关于六氟化铀意外暴露的案例研究。
J Radiol Prot. 2015 Mar;35(1):129-51. doi: 10.1088/0952-4746/35/1/129. Epub 2015 Jan 12.
9
Dissolution rates of airborne uranium in simulated lung fluid.空气中铀在模拟肺液中的溶解速率。
Health Phys. 1982 Oct;43(4):587-90.
10
Physicochemical characterization of Capstone depleted uranium aerosols III: morphologic and chemical oxide analyses.卡普斯通贫化铀气溶胶的物理化学特性III:形态与化学氧化物分析
Health Phys. 2009 Mar;96(3):276-91. doi: 10.1097/01.HP.0000298229.60229.10.

引用本文的文献

1
Uranium Body Clearance Kinetics-A Long-term Follow-up Study of Retired Nuclear Fuel Workers.铀体内清除动力学-退役核燃料工人的长期随访研究。
Health Phys. 2024 Oct 1;127(4):520-535. doi: 10.1097/HP.0000000000001861. Epub 2024 Jul 24.
2
Treatment of Idiopathic Pulmonary Fibrosis by Inhaled Silybin Dry Powder Prepared via the Nanosuspension Spray Drying Technology.纳米混悬液喷雾干燥技术制备的水飞蓟宾吸入干粉治疗特发性肺纤维化
ACS Pharmacol Transl Sci. 2023 May 18;6(6):878-891. doi: 10.1021/acsptsci.3c00033. eCollection 2023 Jun 9.
3
Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.
用于靶向肺部递送的脂质体瑞德西韦吸入溶液作为治疗新冠肺炎的一种新方法。
Asian J Pharm Sci. 2021 Nov;16(6):772-783. doi: 10.1016/j.ajps.2021.09.002. Epub 2021 Oct 21.
4
Mineralogy Controlled Dissolution of Uranium from Airborne Dust in Simulated Lung Fluids (SLFs) and Possible Health Implications.模拟肺液(SLF)中矿物学对空气中粉尘铀溶解的控制及其可能的健康影响
Environ Sci Technol Lett. 2019 Feb 12;6(2):62-67. doi: 10.1021/acs.estlett.8b00557. Epub 2018 Dec 5.
5
Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.经口吸入药物制剂在肺泡屏障处的毒性:初始生物学筛选参数
Drug Deliv. 2017 Nov;24(1):891-905. doi: 10.1080/10717544.2017.1333172.
6
Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.用于肺部肿瘤相关吸入治疗的替莫唑胺干粉制剂。
Pharm Res. 2011 Apr;28(4):762-75. doi: 10.1007/s11095-010-0329-x. Epub 2010 Nov 30.